Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart muscle-specific gene expression using replication defective recombinant adenovirus

T Rothmann1, H A Katus, R Hartong

  • 1Innere Medizin III, University of Heidelberg, Germany.

Gene Therapy
|October 1, 1996
PubMed
Summary

Adenoviruses show promise for heart disease gene therapy. A new vector, Ad-mlcLuc, uses a heart-specific promoter to ensure therapeutic genes are only expressed in cardiomyocytes, improving safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic changing mass behind the left atrium.

BMJ case reports·2025
Same author

Comparative analysis of cryoballoon versus radiofrequency catheter ablation in atrial fibrillation patients with impaired left ventricular ejection fraction.

International journal of cardiology. Heart & vasculature·2025
Same author

Macrophages enhance sodium channel expression in cardiomyocytes.

Basic research in cardiology·2024
Same author

Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin.

Biochemical pharmacology·2024
Same author

The diagnostic accuracy of truncated cardiovascular MR protocols for detecting non-ischemic cardiomyopathies.

The international journal of cardiovascular imaging·2021
Same author

A novel approach to genetic engineering of T-cell subsets by hematopoietic stem cell infection with a bicistronic lentivirus.

Scientific reports·2020

Area of Science:

  • Cardiovascular Research
  • Gene Therapy
  • Molecular Biology

Background:

  • Adenoviruses are potential vectors for gene therapy targeting heart muscle diseases.
  • Broad tissue tropism of adenoviruses limits their safety for gene therapy due to off-target gene expression.
  • Targeted gene delivery to cardiomyocytes is crucial for effective and safe cardiac gene therapy.

Purpose of the Study:

  • To develop a cardiac-specific adenoviral vector for gene therapy.
  • To restrict therapeutic gene expression exclusively to cardiomyocytes.
  • To evaluate the efficacy and specificity of a novel adenoviral vector in vitro and in vivo.

Main Methods:

  • Construction of an adenoviral vector (Ad-mlcLuc) with a ventricle-specific myosin light chain-2 (mlc-2v) promoter driving luciferase expression.

Related Experiment Videos

  • In vitro studies using rat neonatal cardiomyocytes and established cell lines to assess promoter activity.
  • In vivo studies involving cardiac cavity injections in neonatal rats to evaluate myocardial-specific gene expression and tissue distribution of viral DNA.

    • Main Results:

    • Ad-mlcLuc demonstrated specific activity in neonatal cardiomyocytes in vitro, with no activity in other cell lines.
    • In vivo, Ad-mlcLuc achieved myocardial-specific gene expression in rats, despite viral DNA presence in multiple tissues.
    • Expression levels in cardiac muscle cells reached 8-9% of Rous sarcoma virus promoter-driven activity, with negligible activity in thigh muscle.

    Conclusions:

    • The mlc-2v promoter enables heart-specific gene expression within the adenoviral vector system.
    • Ad-mlcLuc represents a promising tool for targeted gene transfer to the myocardium.
    • This targeted approach enhances the safety profile of adenoviral vectors for cardiac gene therapy.